Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SANUWAVE HealthSNWV +1.41%29 3-1 Month Momentum % is -62.10% as of Aug. 19, 2026. GuruFocus rates SNWV with a GF Score™ of 29/100 and a GF Value™ of $12.82 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 847 Medical Devices & Instruments companies, SANUWAVE Health ranks worse than 98.11% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-19), SANUWAVE Health's 3-1 Month Momentum % is -62.10%.
The industry rank for SANUWAVE Health's 3-1 Month Momentum % or its related term are showing as below:
SNWV's 3-1 Month Momentum % is ranked worse than 98.11% of 847
companies
in the Medical Devices & Instruments industry
Industry Median: -6.25
vs SNWV: -62.10
SANUWAVE Health (NAS:SNWV) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
SANUWAVE Health 3-1 Month Momentum % Related Terms
SNWV vs SRTS, COCH, ECOR: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, SANUWAVE Health's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's 3-1 Month Momentum % falls into.
SANUWAVE Health (NAS:SNWV) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (SNWV) has a 3-1 Month Momentum % of -62.10% as of Aug. 19, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on SANUWAVE Health and its competitors. According to the industry distribution chart, SANUWAVE Health ranks #831 out of 847 companies in the Medical Devices & Instruments industry, placing it in the top 98.1%.
Is SANUWAVE Health's 3-1 Month Momentum % too high?
SANUWAVE Health's current 3-1 Month Momentum % is -62.10%. Based on the distribution chart, SANUWAVE Health ranks #831 out of 847 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, SANUWAVE Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's 3-1 Month Momentum % compare to SRTS and COCH?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #831 out of 847 companies for 3-1 Month Momentum %. This places SANUWAVE Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
A good 3-1 Month Momentum % depends on the Medical Devices & Instruments industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on SANUWAVE Health and its competitors. SANUWAVE Health's current 3-1 Month Momentum % is -62.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $12.82, compared to a current price of $5.04 — trading 60.7% below its estimated fair value. The current 3-1 Month Momentum % is -62.10%. SANUWAVE Health's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current 3-1 Month Momentum % is -62.10% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SANUWAVE Health (SNWV) Overvalued in 2026?
Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued.
The current stock price of $5.04 is trading 60.7% below its estimated GF Value™ of $12.82.
GuruFocus considers SANUWAVE Health to be Possible Value Trap.
Key valuation signals for SNWV:
3-1 Month Momentum %: -62.10%
GF Value™: $12.82 vs. price of $5.04 (60.7% below fair value)
No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
29GF Score
Get the complete analysis for SNWV
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SNWV has been successfully added to your 
